3-氰基-4-三氟甲基吡啶 | 13600-43-6

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 3-氰基-4-三氟甲基吡啶
• 中文别名: 4-三氟甲基-3-氰基吡啶；4-三氟甲基烟腈；4-(三氟甲基)烟腈
• 英文名称: 4-(trifluoromethyl)nicotinonitrile
• 英文别名: 3-cyano-4-trifluoromethylpyridine；4-trifluoromethyl-3-cyanopyridine；4-(trifluoromethyl)pyridine-3-carbonitrile
• CAS: 13600-43-6
• 化学式: C₇H₃F₃N₂
• mdl: MFCD00153107
• 分子量: 172.109
• InChiKey: DHIRCRHQLUNYDS-UHFFFAOYSA-N

物化性质

• 沸点：
  75-77°C 15mm
• 密度：
  1.37±0.1 g/cm3(Predicted)
• 溶解度：
  氯仿（微溶）、甲醇（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  36.7
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn
• 安全说明：
  S36/37
• 危险类别码：
  R20/21/22
• 海关编码：
  2933399090

SDS

Name:	4-(Trifluoromethyl)nicotinonitrile 95+% Material Safety Data Sheet
Synonym:	3-Cyano-4-(trifluoromethyl)pyridin
CAS:	13600-43-6

Section 1 - Chemical Product MSDS Name:4-(Trifluoromethyl)nicotinonitrile 95+% Material Safety Data Sheet
Synonym:3-Cyano-4-(trifluoromethyl)pyridin

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
13600-43-6	4-(Trifluoromethyl)nicotinonitrile	95+%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. May cause respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 13600-43-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H3F3N2
Molecular Weight: 172

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents, acids, bases.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 13600-43-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-(Trifluoromethyl)nicotinonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, LIQUID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 13600-43-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 13600-43-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 13600-43-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氰基-4-三氟甲基吡啶 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 10.0h， 以90.1%的产率得到4-三氟甲基烟酸
  参考文献：
  名称：

  一种氟啶虫酰胺及其中间体4-三氟甲基烟酸 的制备方法

  摘要：

  本发明涉及一种氟啶虫酰胺及其中间体4‑三氟甲基烟酸的制备方法，4‑三氟甲基烟酸的制备方法是以氰基乙酰胺、三氟乙酰乙酸乙酯及有机碱为原料，先制备出2,6‑二羟基‑3‑氰基‑4‑三氟甲基吡啶N‑甲基吗啉盐，之后依次经三氯氧磷氯化、催化氢化及水解后即可；氟啶虫酰胺在制备时，先制备出4‑三氟甲基烟酸，之后与氨基乙腈盐酸盐混合，经酰胺化反应后，即得到氟啶虫酰胺。与现有技术相比，本发明制备氟啶虫酰胺的总收率高，成本低廉，操作简便，设备要求较低，能够满足工业化大生产的需求；工艺流程简单，分离提纯容易，反应条件温和。

  公开号：

  CN108191749B
• 作为产物：
  描述：

  (Z)-3-[(4,4,4-trifluoro-3-oxo-1-butenyl)amino]-2-propenenitrile 在 sodium methylate 作用下， 以 甲醇 为溶剂， 反应 2.0h， 以47.2%的产率得到3-氰基-4-三氟甲基吡啶
  参考文献：
  名称：

  N-HETEROARYLNICOTINAMIDE DERIVATIVES

  摘要：

  公开号：

  EP1460071B1

文献信息

• COMPOUNDS AND USES THEREOF
  申请人：Yumanity Therapeutics, Inc.

  公开号：US20190330198A1

  公开（公告）日：2019-10-31

  The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

  本发明涉及用于治疗神经系统疾病的化合物。本发明的化合物可以单独或与其他药用活性剂结合使用，用于治疗或预防神经系统疾病。
• Novel Tricyclic Compounds
  申请人：Wishart Neil

  公开号：US20090312338A1

  公开（公告）日：2009-12-17

  The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

  这项发明提供了一个符合Formula (I)的化合物，其中包括药用盐、前药、生物活性代谢物、立体异构体和同分异构体，其中变量在此处定义。该发明的化合物对治疗免疫和肿瘤疾病有用。
• Copper-Mediated Perfluoroalkylation of Heteroaryl Bromides with (phen)CuR_F
  作者：Michael G. Mormino、Patrick S. Fier、John F. Hartwig

  DOI：10.1021/ol500422t

  日期：2014.3.21

  synthetic goal over the past several decades. Previously, our group reported phenanthroline-ligated perfluoroalkyl copper reagents, (phen)CuRF, which react with aryl iodides and aryl boronates to form the corresponding benzotrifluorides. Herein the perfluoroalkylation of a series of heteroaryl bromides with (phen)CuCF3 and (phen)CuCF2CF3 is reported. The mild reaction conditions allow the process to tolerate

  在过去的几十年里，将全氟烷基连接到有机化合物上一直是一个主要的合成目标。以前，我们的小组报道了菲咯啉连接的全氟烷基铜试剂 (phen)CuR F，它与芳基碘化物和芳基硼​​酸酯反应形成相应的三氟化苯。本文报道了一系列杂芳基溴化物与 (phen)CuCF 3和 (phen)CuCF 2 CF 3的全氟烷基化。温和的反应条件允许该过程耐受许多常见的官能团。使用 (phen)CuCF 2 CF 3 进行全氟乙基化的产率比使用 (phen)CuCF 3 进行三氟甲基化的产率略高，创建了一种生成氟代烷基杂芳烃的方法，这些杂芳烃不易从三氟乙酸衍生物中获得。
• Homogeneous Hydrogenation with a Cobalt/Tetraphosphine Catalyst: A Superior Hydride Donor for Polar Double Bonds and <i>N</i>-Heteroarenes
  作者：Ya-Nan Duan、Xiaoyong Du、Zhikai Cui、Yiqun Zeng、Yufeng Liu、Tilong Yang、Jialin Wen、Xumu Zhang

  DOI：10.1021/jacs.9b11070

  日期：2019.12.26

  The development of catalysts based on earth abundant metals in place of noble metals is becoming a central topic of catalysis. We herein report a cobalt/tetraphosphine complex catalyzed homogeneous hydrogenation of polar unsaturated compounds using an air- and moisture-stable and scalable precatalyst. By activation with potassium hydroxide, this cobalt system shows both high efficiency (up to 24000

  基于地球上丰富的金属代替贵金属的催化剂的开发正在成为催化的中心话题。我们在此报告了一种钴/四膦配合物催化的极性不饱和化合物的均相氢化反应，该反应使用空气和水分稳定且可缩放的预催化剂。通过用氢氧化钾活化，该钴系统显示出高效率（高达 24000 TON 和 12000 h-1 TOF）和对各种醛、酮、亚胺甚至 N-杂芳烃的优异化学选择性。1,2-还原优于 1,4-还原使该方法成为制备烯丙醇和胺的有效方法。同时，具有挑战性的 N-杂芳烃的有效氢化也具有优异的官能团耐受性。机理研究和控制实验表明 CoIH 复合物在催化循环中起到强氢化物供体的作用。对催化循环中的每个钴中间体进行了表征，并提出了一种合理的外球机制。值得注意的是，外部无机碱在该反应中起着多种作用，并且几乎在催化循环的每一步都起作用。
• [EN] HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER
  申请人：ARTIOS PHARMA LTD

  公开号：WO2021028643A1

  公开（公告）日：2021-02-18

  The application relates to heterocyclic amide derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation. (Formula (I))

  该申请涉及杂环酰胺衍生物及其在癌症治疗和预防中的应用，以及含有这些衍生物的组合物和其制备方法。(化学式(I))